Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2024;74:229–63. https://doi.org/10.3322/caac.21834.
Google Scholar
Chen M, Zhu JY, Mu WJ, Guo L. Cysteine dioxygenase type 1 (CDO1): Its functional role in physiological and pathophysiological processes. Genes Dis. 2023;10:877–90. https://doi.org/10.1016/j.gendis.2021.12.023.
Google Scholar
Heafield MT, Fearn S, Steventon GB, Waring RH, Williams AC, Sturman SG. Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson’s and Alzheimer’s disease. Neurosci Lett. 1990;110:216–20. https://doi.org/10.1016/0304-3940(90)90814-p.
Google Scholar
Roman HB, Hirschberger LL, Krijt J, Valli A, Kožich V, Stipanuk MH. The cysteine dioxgenase knockout mouse: altered cysteine metabolism in nonhepatic tissues leads to excess H2S/HS− production and evidence of pancreatic and lung toxicity. Antioxid Redox Signal. 2013;19:1321–36. https://doi.org/10.1089/ars.2012.5010.
Google Scholar
Ueki I, Roman HB, Valli A, Fieselmann K, Lam J, Peters R, et al. Knockout of the murine cysteine dioxygenase gene results in severe impairment in ability to synthesize taurine and an increased catabolism of cysteine to hydrogen sulfide. Am J Physiol Endocrinol Metab. 2011;301:E668–684. https://doi.org/10.1152/ajpendo.00151.2011.
Google Scholar
Brait M, Ling S, Nagpal JK, Chang X, Park HL, Lee J, et al. Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers. PLoS One. 2012;7:e44951 https://doi.org/10.1371/journal.pone.0044951.
Google Scholar
Meller S, Zipfel L, Gevensleben H, Dietrich J, Ellinger J, Majores M, et al. CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients. Epigenetics. 2016;11:871–80. https://doi.org/10.1080/15592294.2016.1241931.
Google Scholar
Hao S, Yu J, He W, Huang Q, Zhao Y, Liang B, et al. Cysteine dioxygenase 1 mediates erastin-induced ferroptosis in human gastric cancer cells. Neoplasia. 2017;19:1022–32. https://doi.org/10.1016/j.neo.2017.10.005.
Google Scholar
Jeschke J, O’Hagan HM, Zhang W, Vatapalli R, Calmon MF, Danilova L, et al. Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines. Clin Cancer Res. 2013;19:12 https://doi.org/10.1158/1078-0432.CCR-12-3751.
Google Scholar
Jurkowska H, Roman HB, Hirschberger LL, Sasakura K, Nagano T, Hanaoka K, et al. Primary hepatocytes from mice lacking cysteine dioxygenase show increased cysteine concentrations and higher rates of metabolism of cysteine to hydrogen sulfide and thiosulfate. Amino Acids. 2014;46:1353–65. https://doi.org/10.1007/s00726-014-1700-8.
Google Scholar
Firlej V, Soyeux P, Nourieh M, Huet E, Semprez F, Allory Y, et al. Overexpression of nucleolin and associated genes in prostate cancer. Int J Mol Sci. 2022;23:4491 https://doi.org/10.3390/ijms23094491.
Google Scholar
Goldman MJ, Craft B, Hastie M, Repečka K, McDade F, Kamath A, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38:675–8. https://doi.org/10.1038/s41587-020-0546-8.
Google Scholar
El-Sayed IY, Daher A, Destouches D, Firlej V, Kostallari E, Maillé P, et al. Extracellular vesicles released by mesenchymal-like prostate carcinoma cells modulate EMT state of recipient epithelial-like carcinoma cells through regulation of AR signalling. Cancer Lett. 2017;410:100–11. https://doi.org/10.1016/j.canlet.2017.09.010.
Google Scholar
Chen S. fastp 1.0: An ultra-fast all-round tool for FASTQ data quality control and preprocessing. Imeta. 2025;4:e70078. https://doi.org/10.1002/imt2.70078.
Google Scholar
Langmead B, Wilks C, Antonescu V, Charles R. Scaling read aligners to hundreds of threads on general-purpose processors. Bioinformatics. 2019;35:421–32. https://doi.org/10.1093/bioinformatics/bty648. Hancock J, éditeur1 févr.
Google Scholar
Danecek P, Bonfield JK, Liddle J, Marshall J, Ohan V, Pollard MO, et al. Twelve years of SAMtools and BCFtools. Gigascience. 2021;10:giab008. https://doi.org/10.1093/gigascience/giab008.
Google Scholar
Amemiya HM, Kundaje A, Boyle AP. The ENCODE blacklist: identification of problematic regions of the genome. Sci Rep. 2019;9:9354. https://doi.org/10.1038/s41598-019-45839-z.
Google Scholar
Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26:841–2. https://doi.org/10.1093/bioinformatics/btq033.
Google Scholar
Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008;9:R137. https://doi.org/10.1186/gb-2008-9-9-r137.
Google Scholar
Grant CE, Bailey TL, Noble WS. FIMO: scanning for occurrences of a given motif. Bioinformatics. 2011;27:1017–8. https://doi.org/10.1093/bioinformatics/btr064.
Google Scholar
Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24–6. https://doi.org/10.1038/nbt.1754.
Google Scholar
Segawa T, Nau ME, Xu LL, Chilukuri RN, Makarem M, Zhang W, et al. Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells. Oncogene. 2002;21:8749–58. https://doi.org/10.1038/sj.onc.1205992.
Google Scholar
Higuchi M, Celino FT, Tamai A, Miura C, Miura T. The synthesis and role of taurine in the Japanese eel testis. Amino Acids. 2012;43:773–81. https://doi.org/10.1007/s00726-011-1128-3.
Google Scholar
Ma G, Zhao Z, Qu Y, Cai F, Liu S, Liang H, et al. Cysteine dioxygenase 1 attenuates the proliferation via inducing oxidative stress and integrated stress response in gastric cancer cells. Cell Death Discov. 2022;8:493 https://doi.org/10.1038/s41420-022-01277-x.
Google Scholar
Choi Jil, Cho EH, Kim SB, Kim R, Kwon J, Park M, et al. Promoter methylation of cysteine dioxygenase type 1: gene silencing and tumorigenesis in hepatocellular carcinoma. Ann Hepatobiliary Pancreat Surg. 2017;21:181–7. https://doi.org/10.14701/ahbps.2017.21.4.181.
Google Scholar
Kwon J, Park M, Kim JH, Lee HW, Kang MC, Park JH. Epigenetic regulation of the novel tumor suppressor cysteine dioxygenase 1 in esophageal squamous cell carcinoma. Tumour Biol. 2015;36:7449–56. https://doi.org/10.1007/s13277-015-3443-x.
Google Scholar
Latil A, Bièche I, Chêne L, Laurendeau I, Berthon P, Cussenot O, et al. Gene expression profiling in clinically localized prostate cancer: a four-gene expression model predicts clinical behavior. Clin Cancer Res. 2003;9:5477–85.
Wang J, Liu D, Zhou W, Wang M, Xia W, Tang Q. Prognostic value of matrix metalloprotease-1/protease-activated receptor-1 axis in patients with prostate cancer. Med Oncol. 2014;31:968. https://doi.org/10.1007/s12032-014-0968-6.
Google Scholar
Minner S, Kraetzig F, Tachezy M, Kilic E, Graefen M, Wilczak W, et al. Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer. Hum Pathol. 2011;42:1946–52. https://doi.org/10.1016/j.humpath.2011.02.017.
Google Scholar
Kristiansen G, Pilarsky C, Wissmann C, Stephan C, Weissbach L, Loy V, et al. ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions. Prostate. 2003;54:34–43. https://doi.org/10.1002/pros.10161.
Google Scholar
Sanders AJ, Owen S, Morgan LD, Ruge F, Collins RJ, Ye L, et al. Importance of activated leukocyte cell adhesion molecule (ALCAM) in prostate cancer progression and metastatic dissemination. Oncotarget. 2019;10:6362–77. https://doi.org/10.18632/oncotarget.27279.
Google Scholar
Hansen AG, Arnold SA, Jiang M, Palmer TD, Ketova T, Merkel A, et al. ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone. Cancer Res. 2014;74:1404–15. https://doi.org/10.1158/0008-5472.CAN-13-1296.
Google Scholar
Jiao J, Hindoyan A, Wang S, Tran LM, Goldstein AS, Lawson D, et al. Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells. PLOS ONE. 2012;7:e42564 https://doi.org/10.1371/journal.pone.0042564.
Google Scholar
Liu DC, Song LL, Li XZ, Liang Q, Zhang ZG, Han CH. Circular RNA circHIPK3 modulates prostate cancer progression via targeting miR-448/MTDH signalling. Clin Transl Oncol. 2021;23:2497–506. https://doi.org/10.1007/s12094-021-02650-5.
Google Scholar
Cai C, Zhi Y, Wang K, Zhang P, Ji Z, Xie C, et al. CircHIPK3 overexpression accelerates the proliferation and invasion of prostate cancer cells through regulating miRNA-338-3p. Onco Targets Ther. 2019;12:3363–72. https://doi.org/10.2147/OTT.S196931.
Google Scholar
Zhou M, Tang J, Huang G, Hong L. Prognostic significance and immune landscape of a cuproptosis-related LncRNA signature in ovarian cancer. Biomedicines. 2024;12:2640 https://doi.org/10.3390/biomedicines12112640.
Google Scholar
Sun R, Yan B, Li H, Ding D, Wang L, Pang J, et al. Androgen receptor variants confer castration resistance in prostate cancer by counteracting antiandrogen-induced ferroptosis. Cancer Res. 2023;83:3192–204. https://doi.org/10.1158/0008-5472.CAN-23-0285.
Google Scholar
Wang R, Yu X, Ye H, Ao M, Xi M, Hou M. LncRNA FAM83H-AS1 inhibits ferroptosis of endometrial cancer by promoting DNMT1-mediated CDO1 promoter hypermethylation. J Biol Chem. 2024;300:107680. https://doi.org/10.1016/j.jbc.2024.107680.
Google Scholar
Zhang J, Yimamu M, Cheng Z, Ji J, Wu L, Feng J, et al. TRIM47-CDO1 axis dictates hepatocellular carcinoma progression by modulating ferroptotic cell death through the ubiquitin‒proteasome system. Free Radic Biol Med. 2024;219:31–48. https://doi.org/10.1016/j.freeradbiomed.2024.04.222.
Google Scholar
Yang J, Sun L, Liu XY, Huang C, Peng J, Zeng X, et al. Targeted demethylation of the CDO1 promoter based on CRISPR system inhibits the malignant potential of breast cancer cells. Clin Transl Med. 2023;13:e1423. https://doi.org/10.1002/ctm2.1423.
Google Scholar
Ku SC, Liu HL, Su CY, Yeh IJ, Yen MC, Anuraga G, et al. Comprehensive analysis of prognostic significance of cadherin (CDH) gene family in breast cancer. Aging (Albany NY). 2022;14:8498–567. https://doi.org/10.18632/aging.204357.
Google Scholar
Figiel S, Vasseur C, Bruyere F, Rozet F, Maheo K, Fromont G. Clinical significance of epithelial-mesenchymal transition markers in prostate cancer. Hum Pathol. 2017;61:26–32. https://doi.org/10.1016/j.humpath.2016.10.013.
Google Scholar
Storm M, Sheng X, Arnoldussen YJ, Saatcioglu F. Prostate cancer and the unfolded protein response. Oncotarget. 2016;7:54051–66. https://doi.org/10.18632/oncotarget.9912.
Google Scholar
Farahani N, Alimohammadi M, Raei M, Nabavi N, Aref AR, Hushmandi K, et al. Exploring the dual role of endoplasmic reticulum stress in urological cancers: Implications for tumor progression and cell death interactions. J Cell Commun Signal. 2024;18:e12054. https://doi.org/10.1002/ccs3.12054.
Google Scholar
de la Calle CM, Shee K, Yang H, Lonergan PE, Nguyen HG. The endoplasmic reticulum stress response in prostate cancer. Nat Rev Urol. 2022;19:708–26. https://doi.org/10.1038/s41585-022-00649-3.
Google Scholar
Cen S, Jiang D, Lv D, Xu R, Hou J, Yang Z, et al. Comprehensive analysis of the biological functions of endoplasmic reticulum stress in prostate cancer. Front Endocrinol (Lausanne). 2023;14:1090277. https://doi.org/10.3389/fendo.2023.1090277.
Google Scholar
Nantermet PV, Xu J, Yu Y, Hodor P, Holder D, Adamski S, et al. Identification of genetic pathways activated by the androgen receptor during the induction of proliferation in the ventral prostate gland. J Biol Chem. 2004;279:1310–22. https://doi.org/10.1074/jbc.M310206200.
Google Scholar
